An AI tool can be FDA-cleared, clinically useful, and still never reach a patient. The barrier is who pays.
Clearance was supposed to be the hard part for medical AI. It isn't. The gap between a cleared algorithm and a bedside is a billing code, and most tools lack one. Reimbursement, not accuracy, is the bottleneck.